HPS Pharmacies wish to advise that Aspen is now supplying Xylocaine with Adrenaline and Marcain with Adrenaline 20mL vials in a new presentation to replace ‘Sterile Theatre Packs that have experienced supply issues. These new products are:

 

Xylocaine 1% with Adrenaline 5 x 20 mL single dose vials

lidocaine (lignocaine) + adrenaline (epinephrine)

ARTG 12015

 

Xylocaine 2% with Adrenaline 5 x 20 mL single dose vials

lidocaine (lignocaine) + adrenaline (epinephrine)

ARTG 12021

 

Marcain 0.25% with adrenaline 1:400,000 5 x 20 mL single dose vials

Bupivacaine + adrenaline (epinephrine)

ARTG 125878

 

Marcain 0.5% with adrenaline 1:200,000 5 x 20 mL single dose vials

Bupivacaine + adrenaline (epinephrine)

ARTG 48329

 

These new products have been introduced to minimise stock shortages of ‘Sterile Theatre Packs’. These products are supplied as non-autoclaved vials without the secondary packaging. The manufacturing process remains the same and the solution inside the vials is, of course, still sterile. However, these non-autoclaved vials should not be placed directly onto the sterile field in theatre.

 

It is anticipated that these new non-autoclaved packs will be available in mid-late April 2022 for Xylocaine with Adrenaline. New presentations of Marcain 0.25% with Adrenaline are expected in late April to early May 2022, with Marcain 0.5% with Adrenaline to follow in mid-May 2022.

‘Sterile Theatre Packs’ are expected to be available in September 2022.

 

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

 

Should you require further information regarding this matter, please contact Aspen on 1300 659 646 or your pharmacist at HPS Pharmacies.

 

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates